The Budget Impact of Cangrelor in the UK for the Treatment of Out-of-Hospital Cardiac Arrest Patients Who Require Percutaneous Coronary Intervention
Cangrelor for OHCA patients who cannot take oral P2Y12 inhibitors may lead to cost savings in the UK.
Authors
- Richard Stork (ORCID: https://orcid.org/0009-0002-4045-5141)
- Caroline Barwood
- Alessia Colucciello (ORCID: https://orcid.org/0009-0004-4696-5825)
- Bhavik Modi (ORCID: https://orcid.org/0000-0002-9413-8291)
- Gina Tarpey
- Rob Cain
Institutions
- University Hospitals of Leicester NHS Trust (GB)
- Chiesi (United Kingdom) (GB)
- Chiesi (Italy) (IT)
Publication Details
- Journal
- ClinicoEconomics and Outcomes Research
- Published
- 2025-03-01
- DOI
- https://doi.org/10.2147/ceor.s475503
- Citations
- 1
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.39